Targeted treatment of psoriasis with adalimumab: a critical appraisal based on a systematic review of the literature
Jochen Schmitt, Gottfried WozelDepartment of Dermatology, Medical Faculty Carl Gustav Carus, Technische Universität Dresden, GermanyAbstract: Psoriasis is a chronic inflammatory disease affecting 2% to 3% of the population in Western countries. Psoriasis is associated with limited quali...
Guardado en:
Autores principales: | Jochen Schmitt, Gottfried Wozel |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2009
|
Materias: | |
Acceso en línea: | https://doaj.org/article/c526050e9bc84e4482597d9c87165996 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Critical appraisal of adalimumab in the treatment of chronic plaque psoriasis
por: Nicolazzo D, et al.
Publicado: (2014) -
Secukinumab: Rapid Efficacy in Psoriasis After Primary Failure With Ustekinumab and Adalimumab
por: Aline Lissa Okita, et al.
Publicado: (2020) -
The effect of biosimilar administration on clinical outcomes in patients with adalimumab‐controlled psoriasis
por: M. Panahi, et al.
Publicado: (2021) -
Critical appraisal of literature comparing minimally invasive extraperitoneal and transperitoneal radical prostatectomy: A systematic review and meta-analysis
por: Panagiotis Kallidonis, et al.
Publicado: (2017) -
Adalimumab Therapy in a Patient with Psoriasis, Down Syndrome, and Concomitant Hepatitis B Virus Infection
por: Madani A, et al.
Publicado: (2021)